- Home
- APGE vs UPST Comparison
APGE vs UPST Comparison
Compare APGE & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APGE | UPST |
|---|---|---|
| Founded | 2022 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.7B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | APGE | UPST |
|---|---|---|
| Price | $90.54 | $34.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $109.67 | $45.84 |
| AVG Volume (30 Days) | 881.1K | ★ 4.1M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 131.25 |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $1,043,857,000.00 |
| Revenue This Year | N/A | $34.45 |
| Revenue Next Year | N/A | $32.64 |
| P/E Ratio | ★ N/A | $73.46 |
| Revenue Growth | N/A | ★ 63.99 |
| 52 Week Low | $34.34 | $23.97 |
| 52 Week High | $95.32 | $85.31 |
Technical Indicators
Market Signals| Indicator | APGE | UPST |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 65.76 |
| Support Level | $73.06 | $24.83 |
| Resistance Level | N/A | $41.64 |
| Average True Range (ATR) | 3.27 | 1.67 |
| MACD | 0.23 | 0.97 |
| Stochastic Oscillator | 64.72 | 85.74 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About UPST Upstart Holdings Inc.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.